MakeMyTrip raises $3.1 billion to repurchase a portion of its Class B shares from China’s Trip Group.
The funding includes a mix of convertible notes and a primary equity offering.
The primary equity follow-on offering raised $1.66 billion by selling 18.4 million new ordinary shares at $90 each.
The remaining funds came from a 5-year convertible senior notes offering with 0% coupon and 35.0% conversion premium.
Morgan Stanley led the offerings as the bookrunner and stabilisation agent.
MakeMyTrip planned to raise $1.4 billion through convertible senior notes and $1.25 billion was netted via notes offering to qualified institutional buyers.
The company increased the number of primary shares from 14 million to 18.4 million for the equity round.
The capital infusion is aimed at reducing Trip Group's stake in MakeMyTrip from 45.95% to 16.90-19.99%.
MakeMyTrip and Trip Group entered a share repurchase agreement to facilitate the stake reduction.
Allegations were made against MakeMyTrip regarding data exposure due to Chinese ownership amidst military tensions.
The deal raises questions about the composition of MakeMyTrip's board post transaction involving its Chinese stakeholders.